These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36223848)

  • 1. Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: A randomized controlled trial.
    Corren J; Larson D; Altman MC; Segnitz RM; Avila PC; Greenberger PA; Baroody F; Moss MH; Nelson H; Burbank AJ; Hernandez ML; Peden D; Saini S; Tilles S; Hussain I; Whitehouse D; Qin T; Villarreal M; Sever M; Wheatley LM; Nepom GT; Sanda S;
    J Allergy Clin Immunol; 2023 Jan; 151(1):192-201. PubMed ID: 36223848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pediatric randomized, controlled trial of German cockroach subcutaneous immunotherapy.
    Zoratti E; Wood R; Pomés A; Da Silva Antunes R; Altman MC; Benson B; Wheatley LM; Cho K; Calatroni A; Little FF; Pongracic J; Makhija M; Khurana Hershey GK; Sherenian MG; Rivera-Spoljaric K; Stokes JR; Gill MA; Gruchalla RS; Chambliss J; Liu AH; Kattan M; Busse PJ; Bacharier LB; Sheehan W; Kim H; Glesner J; Gergen PJ; Togias A; Baucom JL; Visness CM; Sette A; Busse WW; Jackson DJ;
    J Allergy Clin Immunol; 2024 Sep; 154(3):735-744.e10. PubMed ID: 38718950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy comparison and safety analysis of subcutaneous specific immunotherapy with standardized house dust mite allergen in patients with single and multiple allergic rhinitis].
    Huang HH; Xu C; Liu L; Chai RN
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jun; 56(6):774-783. PubMed ID: 35785859
    [No Abstract]   [Full Text] [Related]  

  • 4. Short-term subcutaneous grass pollen immunotherapy under the umbrella of anti-IL-4: A randomized controlled trial.
    Chaker AM; Shamji MH; Dumitru FA; Calderon MA; Scadding GW; Makatsori M; Jones I; He QA; Subramanian KK; Arm JP; Durham SR; Schmidt-Weber CB
    J Allergy Clin Immunol; 2016 Feb; 137(2):452-461.e9. PubMed ID: 26531865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial.
    Corren J; Saini SS; Gagnon R; Moss MH; Sussman G; Jacobs J; Laws E; Chung ES; Constant T; Sun Y; Maloney J; Hamilton JD; Ruddy M; Wang CQ; O'Brien MP
    J Asthma Allergy; 2021; 14():1045-1063. PubMed ID: 34429614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific immunotherapy in local allergic rhinitis: A randomized, double-blind placebo-controlled trial with Phleum pratense subcutaneous allergen immunotherapy.
    Rondón C; Blanca-López N; Campo P; Mayorga C; Jurado-Escobar R; Torres MJ; Canto G; Blanca M
    Allergy; 2018 Apr; 73(4):905-915. PubMed ID: 29168570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal and blood transcriptomic pathways underpinning the clinical response to grass pollen immunotherapy.
    Altman MC; Segnitz RM; Larson D; Jayavelu ND; Smith MT; Patel S; Scadding GW; Qin T; Sanda S; Steveling E; Eifan AO; Penagos M; Jacobson MR; Parkin RV; Shamji MH; Togias A; Durham SR
    J Allergy Clin Immunol; 2023 Nov; 152(5):1247-1260. PubMed ID: 37460024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal allergen-neutralizing antibodies correlate closely with tolerated intranasal allergen challenge dose following grass pollen subcutaneous immunotherapy in patients with local allergic rhinitis.
    Eguiluz-Gracia I; Parkin RV; Layhadi JA; Palmer E; Meng X; Zhu R; Sahiner U; Durham SR; Torres MJ; Mayorga C; Rondon C; Shamji MH
    Allergy; 2024 Aug; 79(8):2197-2206. PubMed ID: 38483174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD).
    Pfaar O; Bachert C; Bufe A; Buhl R; Ebner C; Eng P; Friedrichs F; Fuchs T; Hamelmann E; Hartwig-Bade D; Hering T; Huttegger I; Jung K; Klimek L; Kopp MV; Merk H; Rabe U; Saloga J; Schmid-Grendelmeier P; Schuster A; Schwerk N; Sitter H; Umpfenbach U; Wedi B; Wöhrl S; Worm M; Kleine-Tebbe J; Kaul S; Schwalfenberg A
    Allergo J Int; 2014; 23(8):282-319. PubMed ID: 26120539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-allergen sublingual immunotherapy versus multi-allergen subcutaneous immunotherapy for children with allergic rhinitis.
    Wang ZX; Shi H
    J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):407-411. PubMed ID: 28585143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.
    Pfaar O; Wolf H; Klimek L; Schnitker J; Wüstenberg E
    Clin Ther; 2012 Oct; 34(10):2072-81. PubMed ID: 23063373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study.
    Yukselen A; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB
    Int Arch Allergy Immunol; 2012; 157(3):288-98. PubMed ID: 22041501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential modulation of allergic rhinitis nasal transcriptome by dupilumab and allergy immunotherapy.
    Wipperman MF; Gayvert KM; Atanasio A; Wang CQ; Corren J; Covarrubias A; Setliff I; Chio E; Laws E; Wolfe K; Harel S; Maloney J; Herman G; Orengo JM; Lim WK; Hamon SC; Hamilton JD; O'Brien MP
    Allergy; 2024 Apr; 79(4):894-907. PubMed ID: 38279910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does evidence support the use of cat allergen immunotherapy?
    Dhami S; Agarwal A
    Curr Opin Allergy Clin Immunol; 2018 Aug; 18(4):350-355. PubMed ID: 29870462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous Allergen-Specific Immunotherapy Is Safe in Pediatric Patients with Allergic Rhinitis.
    Pavon-Romero GF; Larenas-Linnemann DE; Xochipa Ruiz KE; Ramirez-Jimenez F; Teran LM
    Int Arch Allergy Immunol; 2021; 182(6):553-561. PubMed ID: 33611315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, patients' perception, and cost of medication in allergic rhinitis with subcutaneous immunotherapy.
    Thanborisutkul K; Khodtecha N; Kulalert P; Sritipsukho P
    Asian Pac J Allergy Immunol; 2023 Sep; 41(3):199-205. PubMed ID: 32828119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Subcutaneous and Sublingual Immunotherapy for House Dust Mite Allergy: A Network Meta-Analysis-Based Comparison.
    Kim JY; Jang MJ; Kim DY; Park SW; Han DH
    J Allergy Clin Immunol Pract; 2021 Dec; 9(12):4450-4458.e6. PubMed ID: 34464748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial.
    Diver S; Khalfaoui L; Emson C; Wenzel SE; Menzies-Gow A; Wechsler ME; Johnston J; Molfino N; Parnes JR; Megally A; Colice G; Brightling CE;
    Lancet Respir Med; 2021 Nov; 9(11):1299-1312. PubMed ID: 34256031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive Prophylactic Administration with a Single Dose of Anti-Fel d 1 Monoclonal Antibodies REGN1908-1909 in Cat Allergen-induced Allergic Rhinitis: A Randomized, Double-Blind, Placebo-controlled Clinical Trial.
    Shamji MH; Singh I; Layhadi JA; Ito C; Karamani A; Kouser L; Sharif H; Tang J; Handijiev S; Parkin RV; Durham SR; Kostic A; Orengo JM; DeVeaux M; Kamal M; Stahl N; Yancopoulos GD; Wang CQ; Radin AR
    Am J Respir Crit Care Med; 2021 Jul; 204(1):23-33. PubMed ID: 33651675
    [No Abstract]   [Full Text] [Related]  

  • 20. Indonesia-Based Study of the Clinical and Cost-Saving Benefits of Subcutaneous Allergen Immunotherapy for Children with Allergic Rhinitis in Private Practice.
    Endaryanto A; Nugraha RA
    Cells; 2021 Jul; 10(7):. PubMed ID: 34360010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.